
Endoscopic Probe Disinfection Market Size, Share & Trends Analysis Report By Type (Endoscopic Probes [Ultrasound (EUS)], Products), By End-use (Hospitals, Ambulatory Surgical Centers (ASCs)), By Region, And Segment Forecasts, 2025 - 2033
Description
Endoscopic Probe Disinfection Market Summary
The global endoscopic probe disinfection market size was estimated at USD 478.78 million in 2024 and is projected to reach USD 791.62 million by 2033, growing at a CAGR of 5.84% from 2025 to 2033. Rising burden of healthcare-associated infections (HAIs) is anticipated to significantly contribute to the growth of the endoscopic probe disinfection market.
According to data released by the European Centre for Disease Prevention and Control (ECDC), in May 2024, it was reported that around 4.3 million hospitalized patients in the EU and European Economic Area experience healthcare-associated infections (HAIs) each year. These figures highlight the persistent challenge of infection transmission within clinical environments, where reusable medical instruments, such as endoscopes, play a critical role. This has intensified regulatory pressure on healthcare facilities to adopt more advanced, validated disinfection and sterilization practices. Subsequently, the rising burden of HAIs directly strengthens demand for reliable endoscopic probe disinfection technologies, positioning them as key tools in safeguarding patient safety and reducing hospital infection rates.
The increasing global burden of cancer and related mortality is significantly influencing the demand for advanced diagnostic and treatment modalities, including endoscopic procedures. According to the American Cancer Society article published in January 2025, the U.S. will face about 2.04 million new cancer diagnoses along with more than 618,000 related deaths in 2025, reflecting the growing burden of the disease. This rising incidence is expected to fuel the use of endoscopic procedures, which remain key to the early detection, staging, and monitoring of various cancers, particularly colorectal and gastrointestinal types. With higher procedural volumes, effective reprocessing endoscopic probes becomes even more key to minimizing infection risks and ensuring safe patient care. As a result, the anticipated increase in cancer cases directly boosts the demand for advanced endoscopic probe disinfection technologies, aligning them as essential in maintaining safety and efficiency within expanding oncology diagnostic services.
The increasing number of healthcare centers, including hospitals, oncology specialty clinics, and diagnostic centers, significantly drives the demand for endoscope probe disinfection solutions. While endoscopic procedures grow globally, reliable, efficient, and compliant reprocessing workflows are required to prevent cross-contamination and healthcare-associated infections (HAIs). With the rise in hospital infrastructure across various regions such as the U.S., UK, Italy, Spain, China, India, Brazil, South Africa, and the UAE, the procedures using both flexible and rigid endoscopes are increasing. According to the American Hospital Association, there were 6,120 hospitals in the U.S. in 2024. Similarly, Canada had 1,300 hospitals in 2021, and the European Union hosts around 15,000 hospitals. As of August 2023, the UK had 1,148 hospitals. This expanding hospital network necessitates a significant increase in disinfection and reprocessing devices.
Government authorities' growing number of regulations and guidelines regarding the disinfection of ultrasound probes is expected to create significant opportunities for market players to develop innovative disinfection products that align with these standards. For instance, in April 2024, the Association for the Advancement of Medical Instrumentation (AAMI) released a recommendation document that outlines sterile processing procedures for ultrasound probes in healthcare settings. This document provides essential guidelines for their disinfection. The increased availability of such documents from governmental and non-profit organizations is expected to boost market growth over the forecast period, offering critical information for effective probe disinfection.
Furthermore, regulatory bodies such as the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) have established strict guidelines and standards for endoscopic probe disinfection to minimize the risk of patient infections linked to inadequate reprocessing. Compliance with these protocols has become a major driver for adopting advanced disinfection technologies. In January 2025, Olympus issued a safety advisory concerning its reusable MAJ-891 Forceps/Irrigation Plug, warning that incomplete or improper cleaning of the probe channel could result in contamination. The advisory highlighted that one patient death had been linked to lapses in disinfection practices and urged healthcare providers to either transition to validated alternative accessories or rigorously follow enhanced disassembly and probe disinfection procedures to ensure patient safety. This instance emphasizes the increasing regulatory scrutiny over endoscopic probe disinfection and reinforces the market’s movement toward safer, more reliable, fail-safe reprocessing solutions.
Global Endoscopic Probe Disinfection Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global endoscopic probe disinfection market report based on type, end use, and region:
The global endoscopic probe disinfection market size was estimated at USD 478.78 million in 2024 and is projected to reach USD 791.62 million by 2033, growing at a CAGR of 5.84% from 2025 to 2033. Rising burden of healthcare-associated infections (HAIs) is anticipated to significantly contribute to the growth of the endoscopic probe disinfection market.
According to data released by the European Centre for Disease Prevention and Control (ECDC), in May 2024, it was reported that around 4.3 million hospitalized patients in the EU and European Economic Area experience healthcare-associated infections (HAIs) each year. These figures highlight the persistent challenge of infection transmission within clinical environments, where reusable medical instruments, such as endoscopes, play a critical role. This has intensified regulatory pressure on healthcare facilities to adopt more advanced, validated disinfection and sterilization practices. Subsequently, the rising burden of HAIs directly strengthens demand for reliable endoscopic probe disinfection technologies, positioning them as key tools in safeguarding patient safety and reducing hospital infection rates.
The increasing global burden of cancer and related mortality is significantly influencing the demand for advanced diagnostic and treatment modalities, including endoscopic procedures. According to the American Cancer Society article published in January 2025, the U.S. will face about 2.04 million new cancer diagnoses along with more than 618,000 related deaths in 2025, reflecting the growing burden of the disease. This rising incidence is expected to fuel the use of endoscopic procedures, which remain key to the early detection, staging, and monitoring of various cancers, particularly colorectal and gastrointestinal types. With higher procedural volumes, effective reprocessing endoscopic probes becomes even more key to minimizing infection risks and ensuring safe patient care. As a result, the anticipated increase in cancer cases directly boosts the demand for advanced endoscopic probe disinfection technologies, aligning them as essential in maintaining safety and efficiency within expanding oncology diagnostic services.
The increasing number of healthcare centers, including hospitals, oncology specialty clinics, and diagnostic centers, significantly drives the demand for endoscope probe disinfection solutions. While endoscopic procedures grow globally, reliable, efficient, and compliant reprocessing workflows are required to prevent cross-contamination and healthcare-associated infections (HAIs). With the rise in hospital infrastructure across various regions such as the U.S., UK, Italy, Spain, China, India, Brazil, South Africa, and the UAE, the procedures using both flexible and rigid endoscopes are increasing. According to the American Hospital Association, there were 6,120 hospitals in the U.S. in 2024. Similarly, Canada had 1,300 hospitals in 2021, and the European Union hosts around 15,000 hospitals. As of August 2023, the UK had 1,148 hospitals. This expanding hospital network necessitates a significant increase in disinfection and reprocessing devices.
Government authorities' growing number of regulations and guidelines regarding the disinfection of ultrasound probes is expected to create significant opportunities for market players to develop innovative disinfection products that align with these standards. For instance, in April 2024, the Association for the Advancement of Medical Instrumentation (AAMI) released a recommendation document that outlines sterile processing procedures for ultrasound probes in healthcare settings. This document provides essential guidelines for their disinfection. The increased availability of such documents from governmental and non-profit organizations is expected to boost market growth over the forecast period, offering critical information for effective probe disinfection.
Furthermore, regulatory bodies such as the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) have established strict guidelines and standards for endoscopic probe disinfection to minimize the risk of patient infections linked to inadequate reprocessing. Compliance with these protocols has become a major driver for adopting advanced disinfection technologies. In January 2025, Olympus issued a safety advisory concerning its reusable MAJ-891 Forceps/Irrigation Plug, warning that incomplete or improper cleaning of the probe channel could result in contamination. The advisory highlighted that one patient death had been linked to lapses in disinfection practices and urged healthcare providers to either transition to validated alternative accessories or rigorously follow enhanced disassembly and probe disinfection procedures to ensure patient safety. This instance emphasizes the increasing regulatory scrutiny over endoscopic probe disinfection and reinforces the market’s movement toward safer, more reliable, fail-safe reprocessing solutions.
Global Endoscopic Probe Disinfection Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global endoscopic probe disinfection market report based on type, end use, and region:
- Type Outlook (Revenue USD Million, 2021 - 2033)
- Endoscopic Probes [Ultrasound (EUS)]
- Convex Probes
- Linear Probes
- Transesophageal (TEE) Probes
- Products
- Instruments
- Consumables
- End Use Outlook (Revenue USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Laboratories and Imaging Centers
- Others
- Regional Outlook (Revenue USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Spain
- Italy
- France
- Denmark
- Norway
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End Use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Endoscopic Probe Disinfection Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising burden of healthcare-associated infections (HAIs)
- 3.2.1.2. Increasing cancer incidence
- 3.2.1.3. Growing number of regulations and guidelines
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of automated disinfection systems
- 3.2.2.2. Product recalls
- 3.3. Endoscope Probe Disinfection Market: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTLE Analysis
- 3.4. Regulatory Framework
- Chapter 4. Endoscopic Probe Disinfection Market Segment Analysis, By Type, 2021 - 2033 (USD Million)
- 4.1. Definition and Scope
- 4.2. Type Market Share Analysis, 2024 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Endoscopic Probe Disinfection Market, by type, 2021 to 2033
- 4.5. Endoscopic Probes [Ultrasound (EUS)]
- 4.5.1. Endoscopic Probes [Ultrasound (EUS)] market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5.2. Convex Probes
- 4.5.2.1. Convex probes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5.3. Linear Probes
- 4.5.3.1. Linear probes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5.4. Transesophageal (TEE) Probes
- 4.5.4.1. Transesophageal (TEE) probes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6. Products
- 4.6.1. Products market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.2. Instruments
- 4.6.2.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.3. Consumables
- 4.6.3.1. Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5. Endoscopic Probe Disinfection Market Segment Analysis, By End Use, 2021-2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. End Use Market Share Analysis, 2024 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Endoscopic Probe Disinfection Market, by End Use, 2021 to 2033
- 5.5. Hospitals
- 5.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
- 5.6. Ambulatory Surgical Centers (ASCs)
- 5.6.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Diagnostic Laboratories and Imaging Centers
- 5.7.1. Diagnostic laboratories and imaging centers market estimates and forecasts, 2021 to 2033 (USD million)
- 5.8. Others
- 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. Endoscopic Probe Disinfection Market Segment Analysis, By Region, By Type, By End Use, 2021 - 2033 (USD Million)
- 6.1. Regional Market Share Analysis, 2024 & 2033
- 6.2. Regional Market Dashboard
- 6.3. Regional Market Snapshot
- 6.4. Endoscope Probe Disinfection Market Share by Region, 2024 & 2033:
- 6.5. North America
- 6.5.1. North America endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.5.2. U.S.
- 6.5.2.1. U.S. endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Canada endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.5.4. Mexico
- 6.5.4.1. Mexico endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6. Europe
- 6.6.1. Europe endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.2. UK
- 6.6.2.1. UK endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.3. Germany
- 6.6.3.1. Germany endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.4. France
- 6.6.4.1. France endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.5. Italy
- 6.6.5.1. Italy endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.6. Spain
- 6.6.6.1. Spain endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.7. Norway
- 6.6.7.1. Norway endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.8. Sweden
- 6.6.8.1. Sweden endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.6.9. Denmark
- 6.6.9.1. Denmark endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Japan endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7.2. China
- 6.7.2.1. China endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7.3. India
- 6.7.3.1. India endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Australia endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. South Korea endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Thailand endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Brazil endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.8.2. Argentina
- 6.8.2.1. Argentina endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. South Africa endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Saudi Arabia endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. UAE endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Kuwait endoscopic probe disinfection market, 2021 - 2033 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Profiles
- 7.3.1. Olympus Corporation
- 7.3.1.1. Company overview
- 7.3.1.2. Financial performance
- 7.3.1.3. Product benchmarking
- 7.3.1.4. Strategic initiatives
- 7.3.2. STERIS plc
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Product benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. GE Healthcare
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Philips Healthcare
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Chison Medical Imaging
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. CS Medical LLC
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. CIVCO Medical Solutions
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Tristel Plc
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Germitec
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Nanosonics
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.